""

GIST (gastrointestinal stromal tumor)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

Title: A Randomized, Double-blind, Placebo-controlled, Phase III Study of Neoadjuvant-Adjuvant Durvalumab and FLOT Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable Gastric and Gastroesophageal Junction Cancer (GC/GEJC).
Phase: III
Contact: Julia Weck / Kontaktperson
Clinical Investigator: PD Dr. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04592913
EudraCT-Number: (siehe EU klinisches Studienregister) 2019-001555-40

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Care

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available